21 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design, Synthesis, and Biological Characterization of Inhaled p38α/β MAPK Inhibitors for the Treatment of Lung Inflammatory Diseases.

Chiesi Farmaceutici
Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion.

Chiesi Farmaceutici
Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β

Chiesi Farmaceutici
Discovery of M

Chiesi Farmaceutici
Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β

Chiesi Farmaceutici
Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases.

Chiesi Farmaceutici
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases.

Chiesi Farmaceutici
HER2 mutation inhibitors

Pfizer
PDE4B INHIBITOR AND USE THEREOF

Xizang Haisco Pharmaceutical
METHIONINE ADENOSYLTRANSERASE 2A INHIBITORS

Ideaya Biosciences
DUAL ANTAGONIST AND USE THEREOF

Nicoya Therapeutics (Shanghai) Co.
Tricyclic Compounds and their Uses

Novartis
INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE

Bristol-Myers Squibb
MACROCYCLES AND THEIR USE

Blossomhill Therapeutics
NEK7 INHIBITORS

Halia Therapeutics
TRK inhibitors useful as anticancer drugs

TYLIGAND BIOSCIENCE (SHANGHAI) LIMITED
TRIAZOLYL-METHYL SUBSTITUTED ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES

Idorsia Pharmaceuticals
Substituted indazoles as IRAK4 inhibitors

Astrazeneca
Bicyclic heterocycles as FGFR4 inhibitors

Incyte
Bis-amido pyridines

Boehringer Ingelheim International